JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Symptomatic brain metastases in melanoma

  • 0Department of Medical Oncology, Alfred Health, Melbourne, Australia.
Experimental Dermatology +

|

April 13, 2024

|

April 13, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Managing symptomatic melanoma brain metastases (MBM) remains difficult, with poorer outcomes than asymptomatic MBM. This review covers challenges, treatments, and future research for symptomatic MBM.

Area Of Science

  • Oncology
  • Neurology
  • Dermatology

Background

  • Metastatic melanoma treatment has advanced, but symptomatic brain metastases present significant challenges.
  • Melanoma brain metastases (MBM) in symptomatic patients have inferior response rates and survival compared to asymptomatic patients.

Purpose Of The Study

  • To review the specific challenges in managing symptomatic melanoma brain metastases (MBM).
  • To discuss current treatment strategies, obstacles, and future research directions for symptomatic MBM.

Main Methods

  • Literature review of current treatment paradigms for symptomatic melanoma brain metastases.
  • Analysis of obstacles hindering improved clinical outcomes.
  • Identification of future research directions.

Main Results

  • Symptomatic MBM patients face poorer prognoses than asymptomatic MBM patients.
  • Current management strategies for symptomatic MBM are discussed, highlighting existing obstacles.

Conclusions

  • Despite advances in metastatic melanoma care, symptomatic MBM remain a critical clinical challenge.
  • Further research is needed to overcome obstacles and improve outcomes for patients with symptomatic MBM.

Keywords: